← USPTO Patent Grants

Anti-variable MUC1* antibodies and uses thereof

Grant US12583927B2 Kind: B2 Mar 24, 2026

Assignee

MINERVA BIOTECHNOLOGIES CORPORATION

Inventors

Cynthia Bamdad, Benoit Smagghe

Abstract

The present application discloses an antibody, or fragment thereof, for the diagnosis, treatment or prevention of cancers wherein the antibody specifically binds to the PSMGFR peptide (SEQ ID NO:2) or a fragment thereof of the peptide.

CPC Classifications

C07K 16/2863 C07K 2317/622 A61K 39/00117 A61K 39/46447

Filing Date

2021-07-12

Application No.

17373609

Claims

8